Penetrium Bioscience Inc. (KOSDAQ:187660)

Penetrium Bioscience Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 14, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	476,441	69,801	44,182	43,575	129,707	-
Market Cap Growth	550.90%	57.99%	1.39%	-66.41%	-	-
Enterprise Value	479,692	67,834	29,262	15,150	100,632	-
Last Close Price	8700.00	1677.00	969.00	1030.00	2970.00	-
PE Ratio	-	-	-	163.51	67.47	-
PS Ratio	48.89	7.16	3.20	2.93	9.28	-
PB Ratio	71.88	10.53	1.30	1.18	3.84	-
P/TBV Ratio	72.34	10.60	1.70	1.48	3.87	-
P/OCF Ratio	-	-	-	48.22	188.20	-
EV/Sales Ratio	49.22	6.96	2.12	1.02	7.20	-
EV/EBITDA Ratio	-	-	-	45.78	36.04	-
EV/EBIT Ratio	-	-	-	-	48.14	-
Debt / Equity Ratio	1.40	1.40	0.02	0.02	0.01	0.02
Debt / EBITDA Ratio	-	-	-	1.94	0.12	0.08
Debt / FCF Ratio	-	-	-	-	-	0.07
Net Debt / Equity Ratio	0.52	0.52	-0.54	-0.93	-0.90	-0.98
Net Debt / EBITDA Ratio	-0.24	-0.24	51.88	-104.03	-10.90	-3.53
Net Debt / FCF Ratio	-0.24	-0.24	1.18	67.13	79.17	-2.74
Asset Turnover	0.27	0.27	0.31	0.35	0.47	0.71
Inventory Turnover	-	-	13.55	34.85	54.23	-
Quick Ratio	0.35	0.35	2.48	4.52	7.43	2.65
Current Ratio	0.55	0.55	3.05	5.07	8.47	3.35
Return on Equity (ROE)	-88.95%	-88.95%	-5.16%	-0.17%	7.13%	27.79%
Return on Assets (ROA)	-27.48%	-27.48%	-2.64%	-1.11%	4.42%	11.87%
Return on Invested Capital (ROIC)	-180.36%	-123.77%	-20.94%	19.99%	91.24%	249.09%
Return on Capital Employed (ROCE)	-200.40%	-200.40%	-5.30%	-2.00%	6.10%	23.40%
Earnings Yield	-4.22%	-28.79%	-6.72%	0.61%	1.48%	-
FCF Yield	-3.01%	-20.55%	-35.11%	-1.18%	-0.30%	-
Buyback Yield / Dilution	-	-	6.34%	-13.32%	-15.87%	-8.84%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.